|
Chronic Kidney Disease Up in the Oldest Old in the US
Monthly Prescribing Reference (HealthDay News) – The prevalence of chronic kidney disease (CKD) has increased among U.S. adults aged ≥80 years, according to research published in the Sept. 25 issue of the Journal of the American Medical Association. C. Barrett Bowling, MD, MSPH, … |
At last, a Bill to control unethical practices in biomedical, health research – The Hindu
The HinduAt last, a Bill to control unethical practices in biomedical, health researchThe HinduIn addition to this Bill, the existing laws including Drugs and Cosmetics Act, the Human Organ Transplantation Act, the Pre-Conception and Pre-Natal Diagnost…
Entia Biosciences Collaborates to Develop Proprietary Antibodies – TheOTCInvestor.com
Entia Biosciences Collaborates to Develop Proprietary AntibodiesTheOTCInvestor.comEntia Biosciences (OTCQB: ERGO), a food science biotechnology company and emerging leader in the field of nutrigenomics, has built a valuable portfolio of patents coverin…
Drug combo found successful in curing hepatitis C – Catholic Online
Drug combo found successful in curing hepatitis CCatholic OnlineDoctors say early diagnosis of condition still vital. The highly contagious liver disease, hepatitis C is the chief reason for liver transplantation in the United States. The majority of p…
Bispecific Antibodies market to be worth USD 4.4 billion by 2023, predicts … – Fort Mills Times
|
Bispecific Antibodies market to be worth USD 4.4 billion by 2023, predicts …
Fort Mills Times Roots Analysis has announced addition of the “Bispecific Antibody Therapeutics Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of molecules undergoing … |
Bispecific Antibodies market to be worth USD 4.4 billion by 2023, predicts … – 4-traders (press release)
|
Bispecific Antibodies market to be worth USD 4.4 billion by 2023, predicts …
4-traders (press release) Roots Analysis has announced addition of the “Bispecific Antibody Therapeutics Market, 2013-2023” report to their offering. The report provides an extensive study of this emerging field, including detailed sales forecast of molecules undergoing … |
Chinese man has new nose grown on his forehead – Evening Standard
Evening Standard |
Chinese man has new nose grown on his forehead
Evening Standard Highly trained: Specialists say the new nose has developed well and transplant surgery will soon be underway A skin tissue expander was placed under Xiaolian’s forehead, which was later cut into the shape of a nose. Cartilage, taken from his ribs, was … Photos of the dayWashington Post Doctors grow nose on man’s foreheadNew York Post Doctors Grow New Nose On Forehead Of Chinese Man, Xiaolian, To Replace …Medical Daily International Business Times all 19 news articles » |
Everolimus effective in women with early failure of adjuvant therapy – The Oncology Report
|
Everolimus effective in women with early failure of adjuvant therapy
The Oncology Report SAN FRANCISCO – In patients who had hormone receptor–positive, HER2-negative advanced breast cancer, everolimus plus exemestane was just as effective among women who had a recurrence during or within a year of adjuvant therapy. The results … |
Everolimus effective in women with early failure of adjuvant therapy – Ob.Gyn. News Digital Network
|
Everolimus effective in women with early failure of adjuvant therapy
Ob.Gyn. News Digital Network SAN FRANCISCO – In patients who had hormone receptor–positive, HER2-negative advanced breast cancer, everolimus plus exemestane was just as effective among women who had a recurrence during or within a year of adjuvant therapy. The results … |
Waseca woman celebrates 30 years with transplanted kidney – Southernminn.com
Waseca woman celebrates 30 years with transplanted kidneySouthernminn.comIn fact, the first successful kidney transplantation had only taken place in 1954, between identical twins. The recipient died eight years after the transplantation. Between 1954 …